12 December 2007
Take a look at what happened in the Retina field in 2007 and what exciting developments are round the corner in 2008.
 |
01 May 2007
Identifying the bottlenecks that are preventing effective management of neovascular AMD.
|
17 October 2007
Identifying the bottlenecks that are preventing effective management of neovascular AMD.
|
13 January 2010
Combination bevacizumab and 25?J/cm2 or 12?J/cm2 PDT significantly reduced the number of bevacizumab treatments required over six months. This study aimed at examining number of treatments, but not visual acuities. However, visual acuities responded favourably in all three groups.
|
01 May 2009
By:Sengul Ozdek, MD
Looking at an activity socring system to define lesions associated with wet AMD by quantifying their activity to determine the need for treatment.
|
01 March 2009
By:Victoria Farrell
Paul Sternberg assesses the new approaches and exciting pipeline of potential dry AMD treatments.
|
01 February 2009
By:Victoria Farrell
Professor Scott Cousins explains how we can use our knowledge of drusen formation to find new ways to combat dry age-related macular degeneration.
|
| 
